Minos-timotheos Matsoukas

Athens, ESYE31, Greece

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 55 publications

Foundation models for low-data drug discovery: mining heterogeneous public and proprietary data in neglected indications.

Foundation models for low-data drug discovery: mining heterogeneous public and proprietary data in neglected indications.

Journal: Expert opinion on drug discovery

Published: August 07, 2026

Design and synthesis of substituted pyrimidines with potent antiviral activity against dengue.

Design and synthesis of substituted pyrimidines with potent antiviral activity against dengue.

Journal: European journal of medicinal chemistry

Published: April 06, 2026

G.AI.A: An Integrated Machine-Learning Platform for Predicting Bioaccumulation and Ecotoxicity of Pharmaceuticals.

G.AI.A: An Integrated Machine-Learning Platform for Predicting Bioaccumulation and Ecotoxicity of Pharmaceuticals.

Journal: Journal of chemical information and modeling

Published: January 16, 2026

Pharmacological Characterization of the Novel CRF1 Receptor Antagonist, Thiazolo[4,5-d] Pyrimidine Analog, M43.

Pharmacological Characterization of the Novel CRF1 Receptor Antagonist, Thiazolo[4,5-d] Pyrimidine Analog, M43.

Journal: Biomolecules

Published: July 19, 2025

Leveraging machine learning and molecular docking techniques to predict novel melanocortin-4 receptor agonists.

Leveraging machine learning and molecular docking techniques to predict novel melanocortin-4 receptor agonists.

Journal: Folia medica

Published: February 17, 2025

GLP-1 receptor agonist properties of a chimeric peptide derived by hybridization of Latrodectus αLatrotoxin and Heloderma Exendin-4.

GLP-1 receptor agonist properties of a chimeric peptide derived by hybridization of Latrodectus αLatrotoxin and Heloderma Exendin-4.

Journal: General and comparative endocrinology

Published: February 08, 2025

Intepirdine Derivatives Possessing Dual 5HT6 Antagonism / HDAC6 Inhibitory Activity.

Intepirdine Derivatives Possessing Dual 5HT6 Antagonism / HDAC6 Inhibitory Activity.

Journal: Chemistry (Weinheim an der Bergstrasse, Germany)

Published: January 06, 2025

Design of Small Non-Peptidic Ligands That Alter Heteromerization between Cannabinoid CB1 and Serotonin 5HT2A Receptors.

Design of Small Non-Peptidic Ligands That Alter Heteromerization between Cannabinoid CB1 and Serotonin 5HT2A Receptors.

Journal: Journal of medicinal chemistry

Published: December 27, 2024

Identification of Small-Molecule Antagonists Targeting the Growth Hormone Releasing Hormone Receptor (GHRHR).

Identification of Small-Molecule Antagonists Targeting the Growth Hormone Releasing Hormone Receptor (GHRHR).

Journal: Journal of chemical information and modeling

Published: August 29, 2024

Novel benzimidazole angiotensin receptor blockers with anti-SARS-CoV-2 activity equipotent to that of nirmatrelvir: computational and enzymatic studies.

Novel benzimidazole angiotensin receptor blockers with anti-SARS-CoV-2 activity equipotent to that of nirmatrelvir: computational and enzymatic studies.

Journal: Expert opinion on therapeutic targets

Published: June 03, 2024

Structural Features Influencing the Bioactive Conformation of Angiotensin II and Angiotensin A: Relationship between Receptor Desensitization, Addiction, and the Blood-Brain Barrier.

Structural Features Influencing the Bioactive Conformation of Angiotensin II and Angiotensin A: Relationship between Receptor Desensitization, Addiction, and the Blood-Brain Barrier.

Journal: International journal of molecular sciences

Published: March 27, 2024

Natural Compounds for Bone Remodeling: A Computational and Experimental Approach Targeting Bone Metabolism-Related Proteins.

Natural Compounds for Bone Remodeling: A Computational and Experimental Approach Targeting Bone Metabolism-Related Proteins.

Journal: International journal of molecular sciences

Published: March 15, 2024

Showing 1-12 of 55

Last Updated: 09/26/2026